EDGAR Filing Documents for 0001144204-08-056503

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-08-056503

Filing Date

2008-10-07

Accepted

2008-10-07 16:33:57

Documents

Period of Report

2008-10-07

Document Format Files

Seq	Description	Document	Type	Size
1		v128249_6k.htm	6-K	26773
2	GRAPHIC	logo.jpg	GRAPHIC	4733
	Complete submission text file	0001144204-08-056503.txt		34819

Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989

Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 081112536
SIC: 2834 Pharmaceutical Preparations